Literature DB >> 32115860

Association between clinical symptoms and post-mortem neuropathology in dementia with Lewy bodies.

Yoshitsugu Kaneko1, Kentaro Hirao1, Shuntaro Serisawa1, Hidekazu Kanetaka1, Soichiro Shimizu1, Hideaki Hirai2, Yukiko Shishido-Hara2, Takahiko Umahara1, Hirofumi Sakurai1, Haruo Hanyu1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32115860      PMCID: PMC7065117          DOI: 10.1111/ggi.13853

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


× No keyword cloud information.
Dear Editor, The association between clinical symptoms and neuropathological changes in dementia with Lewy bodies (DLB) patients has not been elucidated to date. We report a case of an 87‐year‐old man, clinically diagnosed as probable DLB and confirmed as definite DLB on autopsy. Approximately 5 years before his death, his wife noticed that he talked loudly and flapped his upper/lower limbs during his sleep, leading to a diagnosis of rapid eye movement behavior disorder (RBD). Approximately 3 years previously, the patient had noticed forgetfulness, and 1.5 years previously, he recognized occasional visual hallucinations, such as seeing insects on the ceiling, and his Mini‐Mental State Examination score was 26. Neurological examination showed no parkinsonism, including muscle rigidity, tremor, limb paralysis and dysautonomia, such as orthostatic hypotension. Brain perfusion single‐photon emission computed tomography showed significant hypoperfusion in the bilateral temporoparietal/medial occipital lobes. There were no cerebral infarctions or hippocampal atrophy on magnetic resonance imaging. (123)I‐metaiodobenzylguanidine scintigraphy showed a significant reduction in the heart. We diagnosed the patient's condition as probable DLB according to the consortium on DLB international workshop criteria,1 and started donepezil treatment 1.5 years before his death. His visual hallucinations disappeared after donepezil administration and never appeared again. His RBD disappeared after starting treatment with a small amount of clonazepam. He did not show significant progression of cognitive decline nor any parkinsonism during the follow‐up period. Three years before his death, the patient was diagnosed with systemic diffuse large B‐cell lymphoma by biopsy analysis of his inguinal lymph nodes. Despite repetitive relapse and remission, his condition entered complete remission after chemotherapy. However, he eventually presented left upper/lower limb hemiparesis and was admitted to Tokyo Medical University Hospital, Tokyo, Japan. Magnetic resonance imaging showed diffuse large B‐cell lymphoma lesions in the central nervous system 2 months before his death, and he died of tumor hemorrhage and tonsillar herniation. Autopsy showed a macroscopically large hemorrhagic lesion in the right frontal lobe, extending into the intraventricular space (Fig. 1a). Microscopically, invasion of diffuse large B‐cell lymphoma cells was observed (Fig. 1b), but not in the non‐central nervous system areas, including the lymph nodes. Regarding Parkinson's disease‐associated pathology, mild‐to‐moderate depigmentation in the midbrain substantia nigra and moderate‐to‐high depigmentation in the pons locus coeruleus were observed (Fig. 1c,d). Lewy bodies (LB) were observed mainly in the vagal nerve dorsal nucleus (Fig. 1e), locus coeruleus, substantia nigra and limbic cortex, including the mammillary body and parahippocampal gyrus, whereas there were just two LB in the superior frontal gyrus of the neocortex (Fig. 1f). According to pathological diagnostic criteria for DLB,1 semiquantitative evaluation scores were as follows: amygdala, vagus nerve dorsal nucleus, 2–3; locus coeruleus, substantia nigra, entorhinal cortex, 2; nucleus basalis of Meynert, 0–1; and anterior cingulate cortex, middle temporal gyrus cortex, middle frontal gyrus cortex and inferior parietal cortex, 0. Furthermore, few α‐synuclein deposits in the cardiac sympathetic nerve and ileocecum parasympathetic nerve, and substantially decreased expression of tyrosine hydroxylase were observed. Regarding Alzheimer disease pathology, we observed neurofibrillary tangles (Braak stages III–IV) and amyloid (Braak stage B), in accordance with the National Institute on Aging‐Reagan diagnostic criteria.2
Figure 1

Pathological findings of dementia with Lewy bodies on autopsy. (a) Left: Cingulate herniation owing to right frontal lobe tumor hemorrhage and intraventricular perforation was observed (arrow). The area enclosed by a circle was confirmed to be diffuse large B‐cell lymphoma; right: uncal and tonsillar herniation owing to right frontal lobe tumor hemorrhage and intraventricular perforation was observed (arrows). (b) Hematoxylin–eosin staining of the area enclosed by a circle in (a) showing diffuse growth of large atypical lymphocytes. (c) Hematoxylin–eosin staining of the substantia nigra showing a mild decrease in the number of pigmented neurons in the low‐magnified image. (d) Left: Mild‐to‐moderate depigmentation in the midbrain substantia nigra was observed (arrow); right: moderate‐to‐high depigmentation in the pons locus coeruleus was observed. (arrow). (e) α‐Synuclein immunohistochemistry demonstrating Lewy neurites, pale bodies, and brainstem‐type Lewy bodies in the vagal nerve dorsal nucleus (arrows). (f) α‐Synuclein immunohistochemistry showing cortical‐type Lewy bodies in the superior frontal gyrus (arrows).

Pathological findings of dementia with Lewy bodies on autopsy. (a) Left: Cingulate herniation owing to right frontal lobe tumor hemorrhage and intraventricular perforation was observed (arrow). The area enclosed by a circle was confirmed to be diffuse large B‐cell lymphoma; right: uncal and tonsillar herniation owing to right frontal lobe tumor hemorrhage and intraventricular perforation was observed (arrows). (b) Hematoxylineosin staining of the area enclosed by a circle in (a) showing diffuse growth of large atypical lymphocytes. (c) Hematoxylineosin staining of the substantia nigra showing a mild decrease in the number of pigmented neurons in the low‐magnified image. (d) Left: Mild‐to‐moderate depigmentation in the midbrain substantia nigra was observed (arrow); right: moderate‐to‐high depigmentation in the pons locus coeruleus was observed. (arrow). (e) α‐Synuclein immunohistochemistry demonstrating Lewy neurites, pale bodies, and brainstem‐type Lewy bodies in the vagal nerve dorsal nucleus (arrows). (f) α‐Synuclein immunohistochemistry showing cortical‐type Lewy bodies in the superior frontal gyrus (arrows). We considered that the lack of significant progression of the patient's cognitive decline was associated with the transition of his condition from brainstem‐predominant to marginal‐type DLB. This is also probably why he did not show any parkinsonism, although the mild‐to‐moderate depigmentation in the substantia nigra might be associated with compensatory mechanisms, such as increased dopamine turnover in the striatum and hypersensitivity of dopamine receptors.3 Although orthostatic hypotension is a clinical feature of cardiovascular autonomic dysfunction,4 the reason he did not show orthostatic hypotension might be associated with the few α‐synuclein deposits in the cardiac sympathetic nerve. RBD was reported to be associated with LB formation in the pons and medulla oblongata, which controls rapid eye movement sleep.5 We believe the patient's RBD was associated with LB in the vagus nerve dorsal nucleus and locus coeruleus. RBD was recently shown to be associated with reduced myocardial (123)I‐metaiodobenzylguanidine uptake, which is consistent with the present findings.6, 7 Visual hallucinations were reported to be associated with LB pathology, not in the primary visual area, but in the pulvinar nucleus of the thalamus and lateral geniculate nucleus.8, 9 We did not observe any LB in those areas, but his visual hallucinations might be associated with cholinergic deficits, because administration of donepezil had a significant effect. Finally, as an association between DLB and lymphoma has never been reported, we believe his comorbidities occurred coincidentally. Our present case shows the importance of understanding the clinicopathological heterogeneity of DLB for considering appropriate treatment and care.

Disclosure statement

The authors declare no conflict of interest.
  10 in total

1.  Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease.

Authors:  Makoto Takahashi; Masako Ikemura; Teruaki Oka; Toshiki Uchihara; Koichi Wakabayashi; Akiyoshi Kakita; Hitoshi Takahashi; Mari Yoshida; Shuta Toru; Takayoshi Kobayashi; Satoshi Orimo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-05-02       Impact factor: 10.154

2.  Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study.

Authors:  Yoshikuni Mizuno; Kazuko Hasegawa; Tomoyoshi Kondo; Sadako Kuno; Mitsutoshi Yamamoto
Journal:  Mov Disord       Date:  2010-07-30       Impact factor: 10.338

Review 3.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

Review 4.  Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.

Authors:  B F Boeve; M H Silber; C B Saper; T J Ferman; D W Dickson; J E Parisi; E E Benarroch; J E Ahlskog; G E Smith; R C Caselli; M Tippman-Peikert; E J Olson; S-C Lin; T Young; Z Wszolek; C H Schenck; M W Mahowald; P R Castillo; K Del Tredici; H Braak
Journal:  Brain       Date:  2007-04-05       Impact factor: 13.501

5.  Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

Authors:  Daniel Erskine; John-Paul Taylor; Alan Thomas; Daniel Collerton; Ian McKeith; Ahmad Khundakar; Johannes Attems; Christopher Morris
Journal:  Neurosci Bull       Date:  2019-02-06       Impact factor: 5.203

6.  Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies.

Authors:  Daniel Erskine; Alan J Thomas; Johannes Attems; John-Paul Taylor; Ian G McKeith; Christopher M Morris; Ahmad A Khundakar
Journal:  Mov Disord       Date:  2017-01-06       Impact factor: 10.338

Review 7.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

Review 8.  Autonomic Dysfunction in α-Synucleinopathies.

Authors:  José Javier Mendoza-Velásquez; Juan Francisco Flores-Vázquez; Evalinda Barrón-Velázquez; Ana Luisa Sosa-Ortiz; Ben-Min Woo Illigens; Timo Siepmann
Journal:  Front Neurol       Date:  2019-04-12       Impact factor: 4.003

9.  Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.

Authors:  Soichiro Shimizu; Kentaro Hirao; Hidekazu Kanetaka; Nayuta Namioka; Hirokuni Hatanaka; Daisuke Hirose; Raita Fukasawa; Takahiko Umahara; Hirohumi Sakurai; Haruo Hanyu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-02       Impact factor: 9.236

10.  Association between clinical symptoms and post-mortem neuropathology in dementia with Lewy bodies.

Authors:  Yoshitsugu Kaneko; Kentaro Hirao; Shuntaro Serisawa; Hidekazu Kanetaka; Soichiro Shimizu; Hideaki Hirai; Yukiko Shishido-Hara; Takahiko Umahara; Hirofumi Sakurai; Haruo Hanyu
Journal:  Geriatr Gerontol Int       Date:  2020-03       Impact factor: 2.730

  10 in total
  2 in total

Review 1.  Evaluating Infectious, Neoplastic, Immunological, and Degenerative Diseases of the Central Nervous System with Cerebrospinal Fluid-Based Next-Generation Sequencing.

Authors:  Konstantinos I Tsamis; Hercules Sakkas; Alexandros Giannakis; Han Suk Ryu; Constantina Gartzonika; Ilias P Nikas
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

2.  Association between clinical symptoms and post-mortem neuropathology in dementia with Lewy bodies.

Authors:  Yoshitsugu Kaneko; Kentaro Hirao; Shuntaro Serisawa; Hidekazu Kanetaka; Soichiro Shimizu; Hideaki Hirai; Yukiko Shishido-Hara; Takahiko Umahara; Hirofumi Sakurai; Haruo Hanyu
Journal:  Geriatr Gerontol Int       Date:  2020-03       Impact factor: 2.730

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.